Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Sarah Avent

- PMLiVE

The race for a HIV ‘cure’

Supercharging therapies as pharma and patients work together

Roche's Perjeta pertuzumab

Daily Brief: Biosimilar Herceptin can’t make Perjeta cost effective and more

E-cigarettes can save lives - Teva gains approval for EpiPen generic

- PMLiVE

Armoured CAR ‘could overwhelm solid tumour resistance’

Eureka Therapeutics and Memorial Sloan Kettering approach shows promise

Medopad: the up and coming unicorn transforming remote patient monitoring

Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases.

Blue Latitude Health

- PMLiVE

Novo spends $800m to buy biotech and ‘glucose responsive insulin’ tech

Ziylo could help it stay ahead in key insulin franchise

- PMLiVE

Regeneron and Teva close gap on rivals with NGF pain drug

Fasinumab was associated with less pain and improved functional ability compared to placebo

- PMLiVE

Pfizer signs mRNA flu vaccine deal with BioNTech

Pharma giant will take on development and commercial responsibility for candidates

- PMLiVE

Daily Brief: Summit’s $12m lifeline, Biohaven’s speech anxiety pill, Crescendo’s Humabody progress

News from pharma, biotech and healthcare

- PMLiVE

US insurers can peg access to ICER value reviews

Latest step in US pricing evolution

- PMLiVE

Burson Cohn & Wolfe acquires Hirshorn Zuckerman

And CEO Zuckerman will become COO

- PMLiVE

Healthcare Comms appointments

Andrew Martello joins imc, bmore adds to team and ARK gets a new director

If you’re not thinking segmentation, you’re not thinking

Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...

Page & Page Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links